BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18366166)

  • 1. Analysis of the cryptophycin P450 epoxidase reveals substrate tolerance and cooperativity.
    Ding Y; Seufert WH; Beck ZQ; Sherman DH
    J Am Chem Soc; 2008 Apr; 130(16):5492-8. PubMed ID: 18366166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosynthetic characterization and chemoenzymatic assembly of the cryptophycins. Potent anticancer agents from cyanobionts.
    Magarvey NA; Beck ZQ; Golakoti T; Ding Y; Huber U; Hemscheidt TK; Abelson D; Moore RE; Sherman DH
    ACS Chem Biol; 2006 Dec; 1(12):766-79. PubMed ID: 17240975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Versatile Chemoenzymatic Synthesis for the Discovery of Potent Cryptophycin Analogs.
    Schmidt JJ; Khatri Y; Brody SI; Zhu C; Pietraszkiewicz H; Valeriote FA; Sherman DH
    ACS Chem Biol; 2020 Feb; 15(2):524-532. PubMed ID: 31961651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and structure determination of cryptophycins 38, 326, and 327 from the terrestrial cyanobacterium Nostoc sp. GSV 224.
    Chaganty S; Golakoti T; Heltzel C; Moore RE; Yoshida WY
    J Nat Prod; 2004 Aug; 67(8):1403-6. PubMed ID: 15332864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three new cryptophycins from Nostoc sp. GSV 224.
    Subbaraju GV; Golakoti T; Patterson GM; Moore RE
    J Nat Prod; 1997 Mar; 60(3):302-5. PubMed ID: 9090872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptophycins: a novel class of potent antimitotic antitumor depsipeptides.
    Shih C; Teicher BA
    Curr Pharm Des; 2001 Sep; 7(13):1259-76. PubMed ID: 11472266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent approaches for the synthesis of modified cryptophycins.
    Weiss C; Sammet B; Sewald N
    Nat Prod Rep; 2013 Jul; 30(7):924-40. PubMed ID: 23732943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoenzymatic synthesis of cryptophycin/arenastatin natural products.
    Beck ZQ; Aldrich CC; Magarvey NA; Georg GI; Sherman DH
    Biochemistry; 2005 Oct; 44(41):13457-66. PubMed ID: 16216069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of cryptophycin 52 using the Shi epoxidation.
    Hoard DW; Moher ED; Martinelli MJ; Norman BH
    Org Lett; 2002 May; 4(10):1813-5. PubMed ID: 12000306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient and versatile stereoselective synthesis of cryptophycins.
    Mast CA; Eissler S; Stoncius A; Stammler HG; Neumann B; Sewald N
    Chemistry; 2005 Aug; 11(16):4667-77. PubMed ID: 15915529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptophycins-309, 249 and other cryptophycin analogs: preclinical efficacy studies with mouse and human tumors.
    Liang J; Moore RE; Moher ED; Munroe JE; Al-awar RS; Hay DA; Varie DL; Zhang TY; Aikins JA; Martinelli MJ; Shih C; Ray JE; Gibson LL; Vasudevan V; Polin L; White K; Kushner J; Simpson C; Pugh S; Corbett TH
    Invest New Drugs; 2005 Jun; 23(3):213-24. PubMed ID: 15868377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of the epoxide cryptophycin analog, LY355703 to albumin and its effect on in vitro antiproliferative activity.
    Schultz RM; Shih C; Wood PG; Harrison SD; Ehlhardt WJ
    Oncol Rep; 1998; 5(5):1089-94. PubMed ID: 9683814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of the antitumor compound cryptophycin-52 with tubulin.
    Panda D; Ananthnarayan V; Larson G; Shih C; Jordan MA; Wilson L
    Biochemistry; 2000 Nov; 39(46):14121-7. PubMed ID: 11087360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Modification of Light Parameters on the Production of Cryptophycin, Cyanotoxin with Potent Anticancer Activity, in
    Polyzois A; Kirilovsky D; Dufat TH; Michel S
    Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33371249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel cryptophycin antitumor agents: synthesis and cytotoxicity of fragment "B" analogues.
    Patel VF; Andis SL; Kennedy JH; Ray JE; Schultz RM
    J Med Chem; 1999 Jul; 42(14):2588-603. PubMed ID: 10411479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of cryptophycin 1 with tubulin and microtubules.
    Kerksiek K; Mejillano MR; Schwartz RE; Georg GI; Himes RH
    FEBS Lett; 1995 Dec; 377(1):59-61. PubMed ID: 8543019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient synthesis of cryptophycin-52 and novel para-alkoxymethyl unit A analogues.
    Eissler S; Bogner T; Nahrwold M; Sewald N
    Chemistry; 2009 Oct; 15(42):11273-87. PubMed ID: 19760734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A convergent approach to cryptophycin 52 analogues: synthesis and biological evaluation of a novel series of fragment a epoxides and chlorohydrins.
    Al-Awar RS; Ray JE; Schultz RM; Andis SL; Kennedy JH; Moore RE; Liang J; Golakoti T; Subbaraju GV; Corbett TH
    J Med Chem; 2003 Jul; 46(14):2985-3007. PubMed ID: 12825938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptophycin anticancer drugs revisited.
    Rohr J
    ACS Chem Biol; 2006 Dec; 1(12):747-50. PubMed ID: 17240971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cryptophycins: their synthesis and anticancer activity.
    Eggen M; Georg GI
    Med Res Rev; 2002 Mar; 22(2):85-101. PubMed ID: 11857635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.